A Phase 3 Study of Gedatolisib Plus Fulvestrant with and Without Palbociclib in Patients with HR+/HER2-advanced Breast Cancer Previously Treated with a CDK4/6 Inhibitor Plus a Non-Steroidal Aromatase Inhibitor (VIKTORIA-1)
CANCER RESEARCH(2024)
关键词
CDK4/6 Inhibitors
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要